Outcomes of Dialysis Among Patients With End-Stage Renal Disease (ESRD)

• Published in: Curēus (Palo Alto, CA) Vol. 13; no. 8; p. e17006
• Main Authors: Ejaz, Ayesha, Junejo, Abdul Manan, Ali, Muhammad, Ashfaq, Ahsan, Hafeez, Abdul Rauf, Khan, Sadaqat Ali
• Format: Journal Article
• Language: English
• Published: Palo Alto (CA) Cureus 08.08.2021
• Subjects: Nephrology
• ISSN: 2168-8184; 2168-8184
• DOI: 10.7759/cureus.17006

Background Dialysis-associated morbidity and mortality among end-stage renal disease (ESRD) patients has been increasing, despite the advancement in pharmacological treatment and dialysis technology. The aim of this study was to determine the outcomes of dialysis among ESRD patients presenting at the nephrology department of Jinnah Postgraduate Medical Centre (JPMC).  Methodology This cross-sectional study was conducted during the year 2015-2016, including 105 ESRD patients. Data were collected through a structured questionnaire inquiring about patient's demographics and hemodialysis details. The outcomes in terms of survival and death within one month of dialysis were also recorded. The statistical analysis was carried out using SPSS version 21.0 (IBM Corp, Armonk, NY). Results Gender distribution showed that most of the study patients were males (58.1%). The mean duration of ESRD was 7.65 ± 3.69 months while the mean duration of hemodialysis was 36.5 ± 5.65 hours. Among the comorbid conditions, hypertension (69.5%) and diabetes (64.8%) were the most prevalent, followed by renal stones, chronic pyelonephritis, and chronic nephritis. The outcomes indicated mortality among 16.2% of patients; all deceased ESRD patients had diabetes (p < 0.05). Moreover, the duration of hemodialysis was significantly associated with the outcomes of dialysis (p < 0.05). Conclusion In conclusion, a considerable mortality rate was observed among ESRD patients undergoing hemodialysis. Moreover, patient survival was better with the increased duration of dialysis.